Skip to main content
PMC home page
Gut logoLink to Gut
. 1998 Apr;42(4):576–580. doi: 10.1136/gut.42.4.576

Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases

D Rowbotham 1, J Wendon 1, R Williams 1
PMCID: PMC1727084  PMID: 9616324

Abstract

Background—Acute liver failure (ALF) secondary to malignant infiltration of the liver is rare and is diagnosed often only after death. 
Aims—To determine diagnostic factors and particular clinical patterns of illness. 
Methods—Review of case notes from all patients with ALF secondary to hepatic infiltration admitted to this unit over an 18year period (1978-1995). 
Results—From a total of 4020 admissions, 18 patients were identified with ALF attributable to hepatic infiltration. Mean age was 40.7 years. Aetiology was non-Hodgkin's lymphoma in nine patients, Hodgkin's disease in three, infiltrative metastatic carcinoma in four, and haemophagocytosis with no precipitant cause in two cases. Prodromal symptoms were non-specific, but occurred at least two to four weeks before onset of ALF, making the presence of such symptoms of value in differential diagnosis of the cause of ALF. Clinical examination and investigations were unhelpful in distinguishing these cases from more usual causes of ALF. Usually, the clinical course was of rapid deterioration and death from multiorgan failure, and only one patient survived. Diagnosis was made during life in 15 patients. Histology showed evidence of widespread hepatocellular necrosis, with diffuse infiltration by tumour cells rather than focal cellular aggregation. 
Conclusions—Only with accurate histological diagnosis from liver biopsy and institution of specific therapy early in the management of such patients will the best chance of recovery be achieved. In every case of ALF with prodromal symptoms or abnormal imaging, hepatic histology should be obtained by liver biopsy as soon as possible to diagnose infiltrative hepatic disease. 



Keywords: acute liver failure; hepatic infiltration; diagnosis; histology; prognosis

Full Text

The Full Text of this article is available as a PDF (107.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beaugrand M., Trinchet J. C., Callard P., Ferrier J. P. Malignant histocytosis presenting as a fulminant hepatic disease. Gastroenterology. 1983 Feb;84(2):447–448. [PubMed] [Google Scholar]
  2. Bhatia V. N., Parmar U., Subramanian C., Sharma S., Singh D. S. Virulence, haemolysis pattern and haemophagocytosis index of Entamoeba histolytica. Indian J Med Res. 1982 Oct;76:545–551. [PubMed] [Google Scholar]
  3. Biemer J. J. Hepatic manifestations of lymphomas. Ann Clin Lab Sci. 1984 Jul-Aug;14(4):252–260. [PubMed] [Google Scholar]
  4. Bouloux P. M., Scott R. J., Goligher J. E., Kindell C. Fulminant hepatic failure secondary to diffuse liver infiltration by melanoma. J R Soc Med. 1986 May;79(5):302–303. doi: 10.1177/014107688607900513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Braude S., Gimson A. E., Portmann B., Williams R. Fulminant hepatic failure in non-Hodgkin's lymphoma. Postgrad Med J. 1982 May;58(679):301–304. doi: 10.1136/pgmj.58.679.301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Colby T. V., LaBrecque D. R. Lymphoreticular malignancy presenting as fulminant hepatic disease. Gastroenterology. 1982 Feb;82(2):339–345. [PubMed] [Google Scholar]
  7. Crotty C. P., Winkelmann R. K. Cytophagic histiocytic panniculitis with fever, cytopenia, liver failure, and terminal hemorrhagic diathesis. J Am Acad Dermatol. 1981 Feb;4(2):181–194. doi: 10.1016/s0190-9622(81)70022-7. [DOI] [PubMed] [Google Scholar]
  8. Dich N. H., Goodman Z. D., Klein M. A. Hepatic involvement in Hodgkin's disease. Clues to histologic diagnosis. Cancer. 1989 Nov 15;64(10):2121–2126. doi: 10.1002/1097-0142(19891115)64:10<2121::aid-cncr2820641025>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  9. Eras P., Sherlock P. Hepatic coma secondary to metastatic liver disease. Ann Intern Med. 1971 Apr;74(4):581–583. doi: 10.7326/0003-4819-74-4-581. [DOI] [PubMed] [Google Scholar]
  10. FAIRBANK W. H. Three atypical cases of Hodgkin's Disease, presenting with liver failure. Can Med Assoc J. 1953 Sep;69(3):315–317. [PMC free article] [PubMed] [Google Scholar]
  11. Fang J. W., Lau J. Y., Wu P. C., Lai C. L. Fulminant hepatic failure in nonmetastatic renal cell carcinoma. Dig Dis Sci. 1992 Mar;37(3):474–477. doi: 10.1007/BF01307746. [DOI] [PubMed] [Google Scholar]
  12. Ferguson D. J., Allen L. W., Griem M. L., Moran M. E., Rappaport H., Ultmann J. E. Surgical experience with staging laparotomy in 125 patients with lymphoma. Arch Intern Med. 1973 Mar;131(3):356–361. [PubMed] [Google Scholar]
  13. Ghosh P., Fox I. J., Rader A. M., Sorrell M. F. Fulminant hepatic failure as the initial manifestation of non-Hodgkins lymphoma. Am J Gastroenterol. 1995 Dec;90(12):2207–2209. [PubMed] [Google Scholar]
  14. Gill D. S., Spencer A., Cobcroft R. G. High-dose gamma-globulin therapy in the reactive haemophagocytic syndrome. Br J Haematol. 1994 Sep;88(1):204–206. doi: 10.1111/j.1365-2141.1994.tb05000.x. [DOI] [PubMed] [Google Scholar]
  15. Greer J. P., Cousar J. B., Miller R. F., Vogler L. B., Goodin J. C., Graber S. E., Collins R. D. T4+ (helper phenotype) chronic lymphocytic leukemia: case report with liver failure and literature review. Med Pediatr Oncol. 1988;16(5):356–362. doi: 10.1002/mpo.2950160514. [DOI] [PubMed] [Google Scholar]
  16. Harrison H. B., Middleton H. M., 3rd, Crosby J. H., Dasher M. N., Jr Fulminant hepatic failure: an unusual presentation of metastatic liver disease. Gastroenterology. 1981 Apr;80(4):820–825. [PubMed] [Google Scholar]
  17. Hess C. E., Joyce R. A. Acute myeloblastic leukemia presenting as progressive hepatic failure. South Med J. 1981 Aug;74(8):1028–1029. doi: 10.1097/00007611-198108000-00048. [DOI] [PubMed] [Google Scholar]
  18. Hsu S. M., Xie S. S., Hsu P. L., Waldron J. A., Jr Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease. Am J Pathol. 1992 Jul;141(1):129–138. [PMC free article] [PubMed] [Google Scholar]
  19. Huang L. M., Lee C. Y., Lin K. H., Chuu W. M., Lee P. I., Chen R. L., Chen J. M., Lin D. T. Human herpesvirus-6 associated with fatal haemophagocytic syndrome. Lancet. 1990 Jul 7;336(8706):60–61. doi: 10.1016/0140-6736(90)91580-4. [DOI] [PubMed] [Google Scholar]
  20. Hubscher S. G., Lumley M. A., Elias E. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma. Hepatology. 1993 Jan;17(1):70–77. [PubMed] [Google Scholar]
  21. Kerbel R. S., Waghorne C., Korczak B., Lagarde A., Breitman M. L. Clonal dominance of primary tumours by metastatic cells: genetic analysis and biological implications. Cancer Surv. 1988;7(4):597–629. [PubMed] [Google Scholar]
  22. Kim H., Dorfman R. F. Morphological studies of 84 untreated patients subjected to laparotomy for the staging of non-Hodgkin's lymphomas. Cancer. 1974 Mar;33(3):657–674. doi: 10.1002/1097-0142(197403)33:3<657::aid-cncr2820330311>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  23. Kondo H., Date Y. Effects of simultaneous rhG-CSF and methylprednisolone "pulse" therapy on hepatitis A virus-associated haemophagocytic syndrome. Eur J Haematol. 1995 Apr;54(4):271–273. doi: 10.1111/j.1600-0609.1995.tb00683.x. [DOI] [PubMed] [Google Scholar]
  24. Krauss E. A., Ludwig P. W., Sumner H. W. Metastatic carcinoma presenting as fulminant hepatic failure. Am J Gastroenterol. 1979 Dec;72(6):651–654. [PubMed] [Google Scholar]
  25. Lefkowitch J. H., Falkow S., Whitlock R. T. Hepatic Hodgkin's disease simulating cholestatic hepatitis with liver failure. Arch Pathol Lab Med. 1985 May;109(5):424–426. [PubMed] [Google Scholar]
  26. Mandel H., Gozal D., Aizin A., Tavori S., Jaffe M. Haemophagocytosis in hereditary fructose intolerance: a diagnostic dilemma. J Inherit Metab Dis. 1990;13(3):267–269. doi: 10.1007/BF01799369. [DOI] [PubMed] [Google Scholar]
  27. Myszor M. F., Record C. O. Primary and secondary malignant disease of the liver and fulminant hepatic failure. J Clin Gastroenterol. 1990 Aug;12(4):441–446. doi: 10.1097/00004836-199008000-00018. [DOI] [PubMed] [Google Scholar]
  28. Nakagawa K., Miller F. N., Sims D. E., Lentsch A. B., Miyazaki M., Edwards M. J. Mechanisms of interleukin-2-induced hepatic toxicity. Cancer Res. 1996 Feb 1;56(3):507–510. [PubMed] [Google Scholar]
  29. Niggli F., Halle F., Seger R. A. Immunologische Komplikationen bei viszeraler Leishmaniose. Monatsschr Kinderheilkd. 1991 Nov;139(11):772–774. [PubMed] [Google Scholar]
  30. Nouel O., Bernuau J., Lebrec D., Laraki R., Rueff B., Benhamou J. P. Insuffisance hépato-cellulaire grave et hypertension portale dues à un cancer secondaire du foie. Gastroenterol Clin Biol. 1979 Feb;3(2):135–137. [PubMed] [Google Scholar]
  31. Nève P., Decaux G. La maladie de Still de l'adulte. Rev Med Brux. 1991 Dec;12(10):399–401. [PubMed] [Google Scholar]
  32. O'Grady J. G., Schalm S. W., Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993 Jul 31;342(8866):273–275. doi: 10.1016/0140-6736(93)91818-7. [DOI] [PubMed] [Google Scholar]
  33. Ohshima K., Kikuchi M., Eguchi F., Kobari S., Tasaka H. Virus-associated haemophagocytic syndrome with Epstein-Barr virus infection. Virchows Arch A Pathol Anat Histopathol. 1991;419(6):519–522. doi: 10.1007/BF01650682. [DOI] [PubMed] [Google Scholar]
  34. Perera D. R., Greene M. L., Fenster L. F. Cholestasis associated with extrabiliary Hodgkin's disease. Report of three cases and review of four others. Gastroenterology. 1974 Oct;67(4):680–685. [PubMed] [Google Scholar]
  35. Prussia P. R., Mansoor G. A., Edwards C., Jordan O. Haemophagocytic syndrome. West Indian Med J. 1991 Dec;40(4):188–192. [PubMed] [Google Scholar]
  36. Quiquandon I., Plantier I., Hatron P. Y., Chassaing O., Bauters F., Desablens B., Devulder B. Tuberculosis associated haemophagocytic syndrome: two cases with a favourable outcome. Nouv Rev Fr Hematol. 1995;37(2):149–152. [PubMed] [Google Scholar]
  37. Ramanathan M., Duraisamy G. Haemophagocytosis in dengue haemorrhagic fever: a case report. Ann Acad Med Singapore. 1991 Nov;20(6):803–804. [PubMed] [Google Scholar]
  38. Ramanathan M., Karim N. Haemophagocytosis in typhoid fever. Med J Malaysia. 1993 Jun;48(2):240–243. [PubMed] [Google Scholar]
  39. Reinhold U., Abken H., Kukel S., Goeden B., Uerlich M., Neumann U., Kreysel H. W. Tumor-infiltrating lymphocytes isolated from a Ki-1-positive large cell lymphoma of the skin. Phenotypic characterization and analysis of cytokine secretion. Cancer. 1991 Nov 15;68(10):2155–2160. doi: 10.1002/1097-0142(19911115)68:10<2155::aid-cncr2820681012>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  40. Roth A., Kolarić K., Dominis M. Histologic and cytologic liver changes in 120 patients with malignant lymphomas. Tumori. 1978 Feb 28;64(1):45–53. doi: 10.1177/030089167806400105. [DOI] [PubMed] [Google Scholar]
  41. Saló J., Nomdedeu B., Bruguera M., Ordi J., Ginès P., Castells A., Vilella A., Rodés J. Acute liver failure due to non-Hodgkin's lymphoma. Am J Gastroenterol. 1993 May;88(5):774–776. [PubMed] [Google Scholar]
  42. Sasadeusz J., Buchanan M., Speed B. Reactive haemophagocytic syndrome in human immunodeficiency virus infection. J Infect. 1990 Jan;20(1):65–68. doi: 10.1016/s0163-4453(90)92390-7. [DOI] [PubMed] [Google Scholar]
  43. Stark R., Manoharan A. Haemophagocytic syndrome complicating acute lymphoblastic leukaemia. Postgrad Med J. 1989 Apr;65(762):249–252. doi: 10.1136/pgmj.65.762.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Stein A. M., Fawaz K., Tabrizi A., Blanchard R., Hou S. Multifocal malignant hemangioendothelioma presenting as acute hepatitis. A clinicopathologic study. Am J Gastroenterol. 1977 Apr;67(4):370–374. [PubMed] [Google Scholar]
  45. Trewby P. N., Portmann B., Brinkley D. M., Williams R. Liver disease as presenting manifestation of Hodgkin's disease. Q J Med. 1979 Jan;48(189):137–150. [PubMed] [Google Scholar]
  46. Watanabe M., Shimamoto Y., Yamaguchi M., Inada S., Miyazaki S., Sato H. Viral-associated haemophagocytosis and elevated serum TNF-alpha with parvovirus-B19-related pancytopenia in patients with hereditary spherocytosis. Clin Lab Haematol. 1994 Jun;16(2):179–182. doi: 10.1111/j.1365-2257.1994.tb00404.x. [DOI] [PubMed] [Google Scholar]
  47. Wong K. F., Chan J. K., Ng C. S., Chu Y. C. Erythroleukaemia-associated haemophagocytic syndrome. Clin Lab Haematol. 1991;13(4):383–386. doi: 10.1111/j.1365-2257.1991.tb00303.x. [DOI] [PubMed] [Google Scholar]
  48. Woolf G. M., Petrovic L. M., Rojter S. E., Villamil F. G., Makowka L., Podesta L. G., Sher L. S., Memsic L., Vierling J. M. Acute liver failure due to lymphoma. A diagnostic concern when considering liver transplantation. Dig Dis Sci. 1994 Jun;39(6):1351–1358. doi: 10.1007/BF02093804. [DOI] [PubMed] [Google Scholar]
  49. Woolf G. M., Vierling J. M. Disappearing intrahepatic bile ducts: the syndromes and their mechanisms. Semin Liver Dis. 1993 Aug;13(3):261–275. doi: 10.1055/s-2007-1007354. [DOI] [PubMed] [Google Scholar]
  50. Zafrani E. S., Leclercq B., Vernant J. P., Pinaudeau Y., Chomette G., Dhumeaux D. Massive blastic infiltration of the liver: a cause of fulminant hepatic failure. Hepatology. 1983 May-Jun;3(3):428–432. doi: 10.1002/hep.1840030324. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES